AI models for cancer pathology often rely on shortcut correlations rather than detecting true biological signals, compromising reliability.
Key Details
- 1University of Warwick research analyzed 8,000+ patient samples across four cancer types using deep learning pathology models.
- 2Findings show many models predict biomarkers based on confounded visual cues, not causal biological features.
- 3AI models' headline accuracy can drop markedly when evaluated in stratified subgroups controlling for confounding factors.
- 4Reported accuracy for AI (just over 80%) was only modestly better than using tumour grade alone (~75%), already assessed by pathologists.
- 5Authors stress need for bias-aware evaluation and subgroup testing to prevent premature and unsafe clinical deployment.
Why It Matters
This research underscores significant risks of overrelying on AI diagnostic tools that may not generalize well in real-world settings. Robustness, causal modeling, and rigorous validation standards are essential before AI can safely supplement or replace human expertise in pathology and radiology.
Source
EurekAlert
Related News
•EurekAlert
USC Unveils Joint Biomedical Engineering Department Bridging Medicine, Engineering, and Imaging
USC's medical and engineering schools launch a joint biomedical engineering department to accelerate interdisciplinary research and innovation, including imaging and AI.
•EurekAlert
AI Predicts Risks for Outpatient Stem Cell Therapy in Myeloma
Researchers use machine learning to predict adverse events during stem cell therapy for multiple myeloma, improving outpatient safety.
•EurekAlert
AI-Enhanced CT Heart Fat Measurement Boosts Cardiovascular Risk Prediction
AI-derived measurement of heart fat from CT scans significantly improves long-term cardiovascular disease risk prediction.